Mexico City's air pollution has detrimental impact on Alzheimer's disease gene

by IOS PressCredit: Alfred Palmer/WikipediaA new study by researchers at the Universities of Montana, Valle de México, Boise State, and North Carolina, the Centro de Ciencias de la Atmósfera, Uni

Updated on: February 26,2024

Mexico City's air pollution has detrimental impact on Alzheimer's disease gene

by IOS PressCredit: Alfred Palmer/WikipediaA new study by researchers at the Universities of Montana, Valle de México, Boise State, and North Carolina, the Centro de Ciencias de la Atmósfera, Uni

Updated on:February 26,2024

Experiments show untrained patient with prosthetic hand can tell objects apart by touch

Updated on: March 03,2025

Experiments show untrained patient with prosthetic hand can tell objects apart by touch

Updated on:March 03,2025

Dysfunctional endosomes are early sign of neurodegeneration

by University of California - San DiegoFalse-colored scanning electron micrograph of a human neuron. Credit: Image courtesy of Thomas Deerinck, NCMIR, UC San Diego.Writing in the April 11 issue o

Updated on: February 28,2024

Dysfunctional endosomes are early sign of neurodegeneration

by University of California - San DiegoFalse-colored scanning electron micrograph of a human neuron. Credit: Image courtesy of Thomas Deerinck, NCMIR, UC San Diego.Writing in the April 11 issue o

Updated on:February 28,2024

Multiple sclerosis brain atlas could pave way for personalized treatments

by Anne Hammarskjöld,Karolinska InstitutetGraphical abstract. Credit:Neuron(2024). DOI: 10.1016/j.neuron.2024.11.016An international research team, including researchers at Karolinsk

Updated on: January 08,2025

Multiple sclerosis brain atlas could pave way for personalized treatments

by Anne Hammarskjöld,Karolinska InstitutetGraphical abstract. Credit:Neuron(2024). DOI: 10.1016/j.neuron.2024.11.016An international research team, including researchers at Karolinsk

Updated on:January 08,2025

Potential new biomarker for Alzheimer's discovered

by Max Delbrück Center for Molecular MedicineThe Arl8b protein (turquoise) shows an accumulation around the amyloid-b aggregates (red). Cell nuclei are stained blue. The section was analyzed with

Updated on: April 20,2024

Potential new biomarker for Alzheimer's discovered

by Max Delbrück Center for Molecular MedicineThe Arl8b protein (turquoise) shows an accumulation around the amyloid-b aggregates (red). Cell nuclei are stained blue. The section was analyzed with

Updated on:April 20,2024

Team reports major breakthrough in understanding Alzheimer's disease

by Trinity College DublinA human donor Alzheimer's disease brain tissue stained with an agent called 'congo-red', which allows for the visualization of amyloid-beta plaques (red) in t

Updated on: February 26,2024

Team reports major breakthrough in understanding Alzheimer's disease

by Trinity College DublinA human donor Alzheimer's disease brain tissue stained with an agent called 'congo-red', which allows for the visualization of amyloid-beta plaques (red) in t

Updated on:February 26,2024

Alzheimer's-disease-related proteases control axonal guidance by regulating growth cone dynamics

by VIB (the Flanders Institute for Biotechnology)Diagram of the brain of a person with Alzheimer's Disease. Credit: Wikipedia/public domain.BACE1 is the major drug target for Alzheimer's

Updated on: February 26,2024

Alzheimer's-disease-related proteases control axonal guidance by regulating growth cone dynamics

by VIB (the Flanders Institute for Biotechnology)Diagram of the brain of a person with Alzheimer's Disease. Credit: Wikipedia/public domain.BACE1 is the major drug target for Alzheimer's

Updated on:February 26,2024

Common heart drug may slow progression of Huntington's disease

Common heart drug may slow progression of Huntington's diseasebyUniversity of Iowaβ-Blocker Use in Participants With Motor-Manifest Huntington Disease (mmHD) Was Associated With Slower Rate

Updated on: December 16,2024

Common heart drug may slow progression of Huntington's disease

Common heart drug may slow progression of Huntington's diseasebyUniversity of Iowaβ-Blocker Use in Participants With Motor-Manifest Huntington Disease (mmHD) Was Associated With Slower Rate

Updated on:December 16,2024

Scientists discover new receptor for nerve growth factor—a promising target for treating pain

byNew York UniversityNerve growth factor receptor TrkA (in green) and co-receptor NRP1 (in purple) are coexpressed in the same nerve cells in mice. Credit: Bunnett LabResearchers at the NYU Pain

Updated on: December 19,2024

Scientists discover new receptor for nerve growth factor—a promising target for treating pain

byNew York UniversityNerve growth factor receptor TrkA (in green) and co-receptor NRP1 (in purple) are coexpressed in the same nerve cells in mice. Credit: Bunnett LabResearchers at the NYU Pain

Updated on:December 19,2024

Modulation of brain cholesterol: A new line of research in Alzheimer's disease treatment?

by Institut National de la Sante et de la Recherche MedicaleFluorescent labelling of the Tau protein in a hNT human cell. Credit: ©Inserm/U837We have known for some years that Alzheimer&#39

Updated on: February 26,2024

Modulation of brain cholesterol: A new line of research in Alzheimer's disease treatment?

by Institut National de la Sante et de la Recherche MedicaleFluorescent labelling of the Tau protein in a hNT human cell. Credit: ©Inserm/U837We have known for some years that Alzheimer&#39

Updated on:February 26,2024

Extending use of existing Alzheimer's drug could delay move into nursing home

by Alzheimer's Research UKDiagram of the brain of a person with Alzheimer's Disease. Credit: Wikipedia/public domain.Newly-released follow-up analysis from a 2012 clinical trial led by a

Updated on: February 26,2024

Extending use of existing Alzheimer's drug could delay move into nursing home

by Alzheimer's Research UKDiagram of the brain of a person with Alzheimer's Disease. Credit: Wikipedia/public domain.Newly-released follow-up analysis from a 2012 clinical trial led by a

Updated on:February 26,2024

Degrading modified proteins could treat Alzheimer's, other 'undruggable' diseases

by American Chemical SocietyGraphical abstract. Credit:ACS Central Science(2023). DOI: 10.1021/acscentsci.2c01369Certain diseases, including Alzheimer's, are currently considered

Updated on: June 24,2024

Degrading modified proteins could treat Alzheimer's, other 'undruggable' diseases

by American Chemical SocietyGraphical abstract. Credit:ACS Central Science(2023). DOI: 10.1021/acscentsci.2c01369Certain diseases, including Alzheimer's, are currently considered

Updated on:June 24,2024